Short Interest in JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Decreases By 50.0%

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 100 shares, a drop of 50.0% from the January 15th total of 200 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is presently 0.2 days.

Institutional Investors Weigh In On JPMorgan Healthcare Leaders ETF

A hedge fund recently bought a new stake in JPMorgan Healthcare Leaders ETF stock. Krilogy Financial LLC acquired a new position in shares of JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 10,212 shares of the company’s stock, valued at approximately $517,000. Krilogy Financial LLC owned approximately 6.81% of JPMorgan Healthcare Leaders ETF as of its most recent SEC filing.

JPMorgan Healthcare Leaders ETF Price Performance

Shares of JDOC traded down $0.54 during trading hours on Friday, hitting $53.83. 171 shares of the company were exchanged, compared to its average volume of 606. The company has a market capitalization of $8.07 million, a PE ratio of 27.37 and a beta of 0.61. The firm has a fifty day simple moving average of $52.97 and a 200-day simple moving average of $57.46. JPMorgan Healthcare Leaders ETF has a one year low of $50.54 and a one year high of $63.49.

JPMorgan Healthcare Leaders ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 27th. Stockholders of record on Tuesday, December 24th were paid a dividend of $0.3276 per share. The ex-dividend date was Tuesday, December 24th.

About JPMorgan Healthcare Leaders ETF

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation.